Trial for recurring gut infection halted early
NCT ID NCT06536465
Summary
This study tested an oral drug called REC-3964 to see if it could prevent repeat C. diff infections in adults who were at high risk. The goal was to see if the drug was safe and effective after standard antibiotic treatment. The sponsor decided to stop the trial early after only 3 people enrolled, and this decision was not due to safety concerns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GANJ - Toms River - Ocean Family Gastroenterology
Toms River, New Jersey, 08755, United States
-
Southern Star Research Institute, LLC
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.